Maps and graphs have been developed with the support of the Johnson & Johnson Global Public Health
* ALB is referred to Albendazole distributed for STH control plus the 25% of the total quantity of Albendazole distributed for LF elimination (25% is the rate approximately distributed for the treatment of LF in school-age children)
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement. The borders of the map provided reflect the current political geographic status as of the date of publication (2021). However, the technical health information is based on data accurate with respect to the year indicated (2020). The disconnect in this arrangement should be noted but no implications regarding political or terminological status should be drawn from this arrangement as it is purely a function of technical and graphical limitations.
Global donation of Albendazole
Population Pre-SAC e SAC requiring PC for STH
Total tablets of Albendazole* donated (2018-2022) ( download chart)
Population Pre-SAC e SAC treated for STH
Total tablets of Albendazole* donated (2018-2022) ( download chart)